Perceptive Advisors’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Perceptive Advisors's GH Position: Q2 2026 in Review
Perceptive Advisors reduced its Guardant Health (GH) stake by 86% in Q2 2026, selling an estimated $28.1M and leaving 41,327 shares worth $6.2M. The position accounts for 0.09% of the portfolio, ranked #90.
Perceptive Advisors first reported a position in GH in Q2 2019 and has held it in 4 quarters since. The position peaked at $27.7M in Q1 2026. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Perceptive Advisors held 41,327 shares of Guardant Health worth $6.2M as of Q2 2026.
- Perceptive Advisors sold 258,673 Guardant Health shares in Q2 2026, an estimated $28.1M.
- Guardant Health made up 0.09% of Perceptive Advisors's portfolio in Q2 2026, its #90 holding.
- Perceptive Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 4 quarters since.
- Perceptive Advisors's Guardant Health position peaked at $27.7M in Q1 2026.
- 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.